Reactivation of dormant anti-tumor immunity – a clinical perspective of therapeutic immune checkpoint modulation.

Greil, R, Hutterer, E, Hartmann, TN, Pleyer, L. Cell Commun Signal. 2017, 15(1): 5.

Hemeoxygenase-1 as a Novel Driver in Ritonavir-Induced Insulin Resistance in HIV-1-Infected Patients.

Taylor, N, Kremser, I, Auer, S, Hoermann, G, Greil, R, Haschke-Becher, E, Esterbauer, H, Kenner, L, Oberkofler, H. J Acquir Immune Defic Syndr. 2017, 75(1):e13-e20.

Ristocetin-induced platelet aggregation for monitoring of bleeding tendency in CLL treated with ibrutinib.

Kazianka, L, Drucker, C, Skrabs, C, Thomas, W, Melchardt, T, Struve, S, Bergmann, M, Staber, PB, Porpaczy, E, Einberger, C, Heinz, M, Hauswirth, A, Raderer, M, Pabinger, I, Thalhammer, R, Egle, A, Wendtner, CM, Follows, G, Hoermann, G, Quehenberger, P, Jilma, B, Jaeger, U. Leukemia. 2017, 31(5):1117-1122.

A phase 2 study of rituximab plus lenalidomide for mucosa-associated lymphoid tissue lymphoma.

Kiesewetter, B, Willenbacher, E, Willenbacher, W, Egle, A, Neumeister, P, Voskova, D, Mayerhoefer, ME, Simonitsch-Klupp, I, Melchardt, T, Greil, R, Raderer, M. Blood. 2017, 129(3):383-385.

Azacitidine for Front-Line Therapy of Patients with AML: Reproducible Efficacy Established by Direct Comparison of International Phase 3 Trial Data with Registry Data from the Austrian Azacitidine Registry of the AGMT Study Group

Pleyer, L, Dohner, H, Dombret, H, Seymour, JF, Schuh, AC, Beach, CL, Swern, AS, Burgstaller, S, Stauder, R, Girschikofsky, M, Sill, H, Schlick, K, Thaler, J, Halter, B, Spandl, SM, Zebisch, A, Pichler, A, Pfeilstocker, M, Autzinger, EM, Lang, A, Geissler, K, Voskova, D, Sperr, WR, Hojas, S, Rogulj, IM, Andel, J, Greil, R. INT J MOL SCI. 2017, 18(2): 415.

Novel models for prediction of benefit and toxicity with FOLFIRINOX treatment of pancreatic cancer using clinically available parameters.

Schlick, K, Magnes, T, Ratzinger, L, Jaud, B, Weiss, L, Melchardt, T, Greil, R, Egle, A. PLoS One. 2018, 13(11): e0206688.

Supervised versus autonomous exercise training in breast cancer patients: A multicenter randomized clinical trial.

Westphal, T, Rinnerthaler, G, Gampenrieder, SP, Niebauer, J, Thaler, J, Pfob, M, Fuchs, D, Riedmann, M, Mayr, B, Reich, B, Melchardt, T, Mlineritsch, B, Pleyer, L, Greil, R. Cancer Med. 2018.

Does clinical outcome of birch pollen immunotherapy relate to induction of blocking antibodies preventing IgE from allergen binding? A pilot study monitoring responses during first year of AIT.

Huber, S, Lang, R, Steiner, M, Aglas, L, Ferreira, F, Wallner, M, Hawranek, T, Gadermaier, G. Clin Transl Allergy. 2018, 8: 39.

SABCS 2016: systemic therapy for metastatic breast cancer.

Gampenrieder, SP, Rinnerthaler, G, Greil, R. MEMO-MAG EUR MED ONC. 2017, 10(2): 86-89.

Improvement of quality of life and psychological distress after inpatient cancer rehabilitation.

Riedl, D, Giesinger, JM, Wintner, LM, Loth, FL, Rumpold, G, Greil, R, Nickels, A, Licht, T, Holzner, B. WIEN KLIN WOCHENSCHR. 2017, 129(19-20): 692-701.